BusinessVoyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative DiseasesBy Nasdaq OMXFeb 20, 2018, 12:01 PM UTC